{"id":"https://openalex.org/W4362425990","doi":"https://doi.org/10.1158/1078-0432.22440550.v1","title":"Supplementary Data from Vandetanib, Designed to Inhibit VEGFR2 and EGFR Signaling, Had No Clinical Activity as Monotherapy for Recurrent Ovarian Cancer and No Detectable Modulation of VEGFR2","display_name":"Supplementary Data from Vandetanib, Designed to Inhibit VEGFR2 and EGFR Signaling, Had No Clinical Activity as Monotherapy for Recurrent Ovarian Cancer and No Detectable Modulation of VEGFR2","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4362425990","doi":"https://doi.org/10.1158/1078-0432.22440550.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22440550.v1","doi":"https://doi.org/10.1158/1078-0432.22440550.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22440550.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.22440550.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028772864","display_name":"Christina M. Annunziata","orcid":"https://orcid.org/0000-0003-2033-6532","observed_orcids":["https://orcid.org/0000-0003-2033-6532"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christina M. Annunziata","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112419390","display_name":"Amanda J. Walker","orcid":"https://orcid.org/0000-0003-2163-2202","observed_orcids":["https://orcid.org/0000-0003-2163-2202"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amanda J. Walker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037416583","display_name":"Lori M. Minasian","orcid":"https://orcid.org/0000-0002-0472-4079","observed_orcids":["https://orcid.org/0000-0002-0472-4079"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lori Minasian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103635393","display_name":"Minshu Yu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Minshu Yu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110266399","display_name":"Herbert L. Kotz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Herbert Kotz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026470145","display_name":"Bradford J. Wood","orcid":"https://orcid.org/0000-0002-4297-0051","observed_orcids":["https://orcid.org/0000-0002-4297-0051"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bradford J. Wood","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044681793","display_name":"Katherine R. Calvo","orcid":"https://orcid.org/0000-0002-0771-4191","observed_orcids":["https://orcid.org/0000-0002-0771-4191"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katherine Calvo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082080836","display_name":"Peter L. Choyke","orcid":"https://orcid.org/0000-0003-1086-8826","observed_orcids":["https://orcid.org/0000-0003-1086-8826"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Choyke","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016446320","display_name":"Daniel Kimm","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Kimm","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044239219","display_name":"Seth M. Steinberg","orcid":"https://orcid.org/0000-0002-8280-551X","observed_orcids":["https://orcid.org/0000-0002-8280-551X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seth M. Steinberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5005621340","display_name":"Elise C. Kohn","orcid":"https://orcid.org/0000-0002-8631-9762","observed_orcids":["https://orcid.org/0000-0002-8631-9762"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elise C. Kohn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10390","display_name":"Ovarian function and disorders","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vandetanib","display_name":"vandetanib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/vegfr2","display_name":"VEGFR2","score":0.9010000228881836},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.8370000123977661},{"id":"https://openalex.org/keywords/recurrent-ovarian-cancer","display_name":"recurrent ovarian cancer","score":0.9929999709129333},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.656000018119812},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.7639999985694885},{"id":"https://openalex.org/keywords/vegfr2-signaling","display_name":"VEGFR2 signaling","score":0.6349999904632568},{"id":"https://openalex.org/keywords/clinical-activity","display_name":"clinical activity","score":0.49799999594688416}],"concepts":[{"id":"https://openalex.org/C2780333294","wikidata":"https://www.wikidata.org/wiki/Q7914515","display_name":"Vandetanib","level":4,"score":0.8652130961418152},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.6870354413986206},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5933220982551575},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4949769377708435},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4574822783470154},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4511883556842804},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43465977907180786},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4209168553352356},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.32676616311073303},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.28899866342544556},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.1592799723148346}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.22440550.v1","doi":"https://doi.org/10.1158/1078-0432.22440550.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22440550.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22440550","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Data_from_Vandetanib_Designed_to_Inhibit_VEGFR2_and_EGFR_Signaling_Had_No_Clinical_Activity_as_Monotherapy_for_Recurrent_Ovarian_Cancer_and_No_Detectable_Modulation_of_VEGFR2/22440550","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22440550.v1","doi":"https://doi.org/10.1158/1078-0432.22440550.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22440550.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1964889141","https://openalex.org/W3031904223","https://openalex.org/W2164048873","https://openalex.org/W2095126639","https://openalex.org/W223334458","https://openalex.org/W2016546844","https://openalex.org/W4361885160","https://openalex.org/W4361920103","https://openalex.org/W2968760090","https://openalex.org/W4361885524"],"abstract_inverted_index":{"Supplementary":[0],"Data":[1],"from":[2],"Vandetanib,":[3],"Designed":[4],"to":[5],"Inhibit":[6],"VEGFR2":[7,26],"and":[8,21],"EGFR":[9],"Signaling,":[10],"Had":[11],"No":[12,22],"Clinical":[13],"Activity":[14],"as":[15],"Monotherapy":[16],"for":[17],"Recurrent":[18],"Ovarian":[19],"Cancer":[20],"Detectable":[23],"Modulation":[24],"of":[25]},"counts_by_year":[],"updated_date":"2026-09-21T07:43:02.447757","created_date":"2025-10-10T00:00:00"}